CN117202904A - 红血球及/或血红蛋白增加用组合物 - Google Patents

红血球及/或血红蛋白增加用组合物 Download PDF

Info

Publication number
CN117202904A
CN117202904A CN202280030901.8A CN202280030901A CN117202904A CN 117202904 A CN117202904 A CN 117202904A CN 202280030901 A CN202280030901 A CN 202280030901A CN 117202904 A CN117202904 A CN 117202904A
Authority
CN
China
Prior art keywords
composition
ergothioneine
salt
hemoglobin
improving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280030901.8A
Other languages
English (en)
Chinese (zh)
Inventor
胜部谅
渡边斉志
村山宣人
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Holdings Ltd
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of CN117202904A publication Critical patent/CN117202904A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN202280030901.8A 2021-04-26 2022-03-25 红血球及/或血红蛋白增加用组合物 Pending CN117202904A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021-074320 2021-04-26
JP2021074320 2021-04-26
PCT/JP2022/014221 WO2022230487A1 (ja) 2021-04-26 2022-03-25 赤血球及び／又はヘモグロビン増加用組成物

Publications (1)

Publication Number Publication Date
CN117202904A true CN117202904A (zh) 2023-12-08

Family

ID=83847365

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280030901.8A Pending CN117202904A (zh) 2021-04-26 2022-03-25 红血球及/或血红蛋白增加用组合物

Country Status (7)

Country Link
US (1) US20240180876A1 (https=)
EP (1) EP4331580A4 (https=)
JP (1) JPWO2022230487A1 (https=)
CN (1) CN117202904A (https=)
AU (1) AU2022267109A1 (https=)
TW (1) TW202308616A (https=)
WO (1) WO2022230487A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025157153A1 (zh) * 2024-01-25 2025-07-31 南京纽邦生物科技有限公司 用于增强运动表现的方法及组合物

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020376265B2 (en) * 2019-10-28 2026-02-19 Suntory Holdings Limited Composition for sleep improvement comprising ergothioneine or salt thereof
WO2024038821A1 (ja) * 2022-08-17 2024-02-22 サントリーホールディングス株式会社 フレイル予防又は改善用組成物、及び、加齢に伴う身体活動能力低下を抑制又は改善するための組成物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020110604A1 (en) * 2000-08-11 2002-08-15 Ashni Naturaceuticals, Inc. Composition exhibiting synergistic antioxidant activity
US20140121156A1 (en) * 2011-06-13 2014-05-01 Entia Biosciences, Inc. Nutritional approach to the control of anemia, diabetes and other diseases or conditions and prevention of associated comorbid states with the use of ergothioneine
US20150157648A1 (en) * 2012-06-26 2015-06-11 Entia Biosciences, Inc. Nutritional approach to improving athletic performance and reducing injury with l-ergothioneine and/or vitamin d2

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5658479B2 (ja) 2009-04-27 2015-01-28 株式会社岩出菌学研究所 脂肪減少等の活性を示す組成物
JP5904378B2 (ja) * 2013-02-28 2016-04-13 株式会社エル・エスコーポレーション 抗うつ剤
CN112352046A (zh) * 2018-06-29 2021-02-09 长濑产业株式会社 麦角硫因、抗坏血酸2-葡糖苷、抗坏血酸和它们的组合的成肌分化促进作用

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020110604A1 (en) * 2000-08-11 2002-08-15 Ashni Naturaceuticals, Inc. Composition exhibiting synergistic antioxidant activity
US20140121156A1 (en) * 2011-06-13 2014-05-01 Entia Biosciences, Inc. Nutritional approach to the control of anemia, diabetes and other diseases or conditions and prevention of associated comorbid states with the use of ergothioneine
US20150157648A1 (en) * 2012-06-26 2015-06-11 Entia Biosciences, Inc. Nutritional approach to improving athletic performance and reducing injury with l-ergothioneine and/or vitamin d2

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
門馬 怜子，等: "Relationship between anemia and circulating levels of amino acids in female endurance athletes", 体力科学, 31 December 2017 (2017-12-31), pages 391 - 397, XP055980454, DOI: 10.7600/jspfsm.66.391 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025157153A1 (zh) * 2024-01-25 2025-07-31 南京纽邦生物科技有限公司 用于增强运动表现的方法及组合物

Also Published As

Publication number Publication date
EP4331580A1 (en) 2024-03-06
EP4331580A4 (en) 2025-03-19
US20240180876A1 (en) 2024-06-06
WO2022230487A1 (ja) 2022-11-03
AU2022267109A1 (en) 2023-10-12
TW202308616A (zh) 2023-03-01
JPWO2022230487A1 (https=) 2022-11-03

Similar Documents

Publication Publication Date Title
TWI407963B (zh) Contains the composition of riboflavin and sesamin
CN117202904A (zh) 红血球及/或血红蛋白增加用组合物
JP7764471B2 (ja) 腎機能の低下抑制又は改善用組成物
KR20230152614A (ko) 인지 기능 속도 개선용 조성물
JP2024069498A (ja) エルゴチオネイン又はその塩を含有する睡眠改善用組成物
CN117255683A (zh) 免疫细胞的代谢促进用组合物
CN119604289A (zh) 预防或改善衰弱用组合物，以及用于抑制或改善伴随年龄增长的身体活动能力下降的组合物
CN117202798A (zh) 白血球及/或嗜碱细胞增加用组合物
CN117241680A (zh) 脂肪分解促进用组合物
JP7796117B2 (ja) 血中コレステロール値改善用組成物
CN118251219A (zh) 组胺n-甲基转移酶阻碍用组合物
HK40103316A (zh) 红血球及/或血红蛋白增加用组合物
CN121001582A (zh) 含有麦角硫因或其盐的用于预防、减轻或改善中暑或脱水症的组合物及用于调节细胞内外水分的组合物
WO2024172002A1 (ja) エルゴチオネインを含有する血管拡張用組成物
WO2024172003A1 (ja) エルゴチオネインを含有する筋萎縮抑制用組成物及びＳｒｃチロシンキナーゼ阻害用組成物
HK40075030A (en) Composition for sleep improvement comprising ergothioneine or salt thereof
HK40103317A (zh) 肾功能的降低抑制或改善用组合物
WO2025063190A1 (ja) エルゴチオネインを含有する組成物
KR20250043432A (ko) 경구 조성물과, 에르고티오네인 또는 그의 염에서 유래하는 고미 및 젖 유래 세라마이드 함유 소재에서 유래하는 냄새를 억제하는 방법
CN118414094A (zh) 口服组合物以及抑制来自麦角硫因的苦味的方法
HK40104490A (zh) 脂肪分解促进用组合物

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40103316

Country of ref document: HK